Latest code release is live with fixes to most major bugs resulting from our 15-month rewrite of the underlying code base, including: Ignores, Ignore Replies, View Thread, Hide Replies, Inbox Folder Access, & other random issues. Please report any remaining bugs you are aware of & we'll get cranking on the next round of fixes. Send PM to Admin, email to admin@investorvillage.com. Thanks!
I am a physician who retired at 48 thanks to a lot of success in the market. My wife is a medical oncologist. I have based much of my DCTH thinking on the opinions of eight oncologists. Three are university based and five in private practice.
DOCOTF is impressed by the Euro reception for CS. If that positive response translates into a lot of cases, then DCTH will probably succeed. But we haven't seen that yet. The number of cases done is small. That is one of the Fundamental reasons why I am not buying here. Lack of institutional interest is another big one. From a Technical standpoint, the chart is AWFUL.
Someone buying DCTH at $1.50 is likely to see one of two outcomes. It goes to zero, or it goes to $8-$10. Why guess? If shares move up to $3.00, with some volume and institutional buying (same thing), then I will be happy to join the fun. Not participating in the initial gain is a cheap price for reducing risk. The first rule of investing is Don't Lose Money!
